Skip to content
Health Horizon

Health Horizon

Healthy Body Your Time in Health

Primary Menu Health Horizon

Health Horizon

  • Health Horizon
  • Health Technology Innovation
  • Global Health and the Health Crisis
  • Mental Health and Emotional Wellbeing
  • Genetics and Gene Therapy Research
  • Contact Us
    • Advertise Here
    • Privacy Policy
    • Sitemap
  • Home
  • Market
  • Page 3

Market

Global Pain Management Device Market Soars with 9.24% CAGR through 2029, Driving Innovation in Healthcare Technology with Neurostimulation Devices at the Forefront
  • Health Technology Innovation

Global Pain Management Device Market Soars with 9.24% CAGR through 2029, Driving Innovation in Healthcare Technology with Neurostimulation Devices at the Forefront

admin May 2, 2024 0

Company LogoGlobal Pain Management Device MarketGlobal Pain Management Device MarketDublin, May 01, 2024 (GLOBE NEWSWIRE) -- The "Pain Management Device...

Read MoreRead more about Global Pain Management Device Market Soars with 9.24% CAGR through 2029, Driving Innovation in Healthcare Technology with Neurostimulation Devices at the Forefront
Gene Therapy Market Is Expecting Progress at USD 38.33 Billion by 2030
  • Genetics and Gene Therapy Research

Gene Therapy Market Is Expecting Progress at USD 38.33 Billion by 2030

admin April 21, 2024 0

The Gene Therapy Market, valued at USD 9.42 billion in 2023, is expected to reach USD 38.33 billion by 2030,...

Read MoreRead more about Gene Therapy Market Is Expecting Progress at USD 38.33 Billion by 2030
Unlocking health tech innovation: How AIIMS is nurturing startups from lab to market | Health and Wellness News
  • Health Technology Innovation

Unlocking health tech innovation: How AIIMS is nurturing startups from lab to market | Health and Wellness News

admin March 29, 2024 0

What if a powder derived from stem cells could heal your accident wounds and regenerate tissues without reconstruction surgery? Or...

Read MoreRead more about Unlocking health tech innovation: How AIIMS is nurturing startups from lab to market | Health and Wellness News

Posts pagination

Previous 1 2 3

Recent Posts

  • CDC in Nigeria | Global Health
  • Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Global Health Updates: US & WHO News
  • Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

Archives

  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023

Categories

  • Genetics and Gene Therapy Research
  • Global Health and the Health Crisis
  • Health Horizon
  • Health Technology Innovation
  • Mental Health and Emotional Wellbeing
  • News

Visit Us

Insiemesenza

You may have missed

CDC in Nigeria | Global Health
  • Global Health and the Health Crisis

CDC in Nigeria | Global Health

admin February 23, 2026 0
Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News
  • Mental Health and Emotional Wellbeing

Delhi schools mindful of emotional wellbeing, but face counsellor shortage crisis | Delhi News

admin February 23, 2026 0
Global Health Updates: US & WHO News
  • Global Health and the Health Crisis

Global Health Updates: US & WHO News

admin February 22, 2026 0
Unlocking the Potential of Gene Therapy for Genetic Skin Disorders
  • Genetics and Gene Therapy Research

Unlocking the Potential of Gene Therapy for Genetic Skin Disorders

admin February 21, 2026 0
Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096
  • Health Horizon

Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096

admin February 21, 2026 0
Copyright © All rights reserved. | CoverNews by AF themes.